Impact of prior oral anticoagulation therapies on post‐discharge outcomes after COVID‐19: Results from a global federated health network analysis

Documenti analoghi

• Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients
  di: Yao Du, et al.
  Pubblicazione: (2025)
• Myths and challenges around anticoagulation in atrial fibrillation: A practicing clinician's perspective
  di: K. E. Juhani Airaksinen, et al.
  Pubblicazione: (2025)
• Apixaban in patients with nonvalvular atrial fibrillation, heart failure and low body weight: A report from a global federated research dataset
  di: Luca Monzo, et al.
  Pubblicazione: (2025)
• Does hospitalisation improve oral anticoagulant optimisation in patients with atrial fibrillation?
  di: Belayneh Kefale, et al.
  Pubblicazione: (2025)
• The impact of clinical phenotypes of coronary artery disease on outcomes in patients with atrial fibrillation: A post‐hoc analysis of GLORIA‐AF registry
  di: Bi Huang, et al.
  Pubblicazione: (2025)